A Study for the Evaluation of Efficacy and Safety of Prolia in Participants With Glucocorticoid-induced Osteoporosis in Mainland China

Status:
RECRUITING

Trial end date:
2027-05-24

Target enrollment:

Participant gender:

The main objective of this study is to evaluate the efficacy of Prolia in improving bone mass density (BMD) of lumbar spine at month 12.

PHASE4

Amgen

Denosumab